Understanding How CMS Will Track Antipsychotic Use In Nursing Homes - Part I

About this episode

The episode discusses how CMS will monitor antipsychotic use in nursing homes and the implications of changing national averages.

We unpack how CMS will monitor antipsychotic use in nursing homes, why the national average is changing, and what datasets will be cross-checked to produce public quality measures. We set the stage for part two, where we dig into practical steps to strengthen documentation, data integrity, and care processes. • OIG findings and the CMS refocus • reasons for increased oversight and risk signals • how MDS and claims will be cross-referenced • shift in national average to 16.9...

Topics covered

• CMS
• antipsychotic use
• nursing homes
• data integrity
• quality measures

Keywords

• OIG findings
• oversight
• risk signals
• MDS
• claims

More episodes of Vital Compliance Insights

• How Compliance Committees Can Spot Hidden Fall Risks In Nursing Homes · March 24, 2026 · 8 min
• Accountability, Prevention, And The True Cost Of Missed Falls · February 28, 2026 · 24 min
• Caregiving Series Episode 1: Introductions · February 27, 2026 · 41 min
• Caregiving Series Episode 2: A Caregiver's Grief · February 27, 2026 · 31 min
• Your Dashboard Looks Great… Until The Numbers Don’t · February 25, 2026 · 9 min
• CMS Antipsychotic QM - Part 2 - Steps For Safer Antipsychotic Use · January 23, 2026 · 24 min